What You Should Know:
– Heidi Health, a fast-growing Melbourne, Australian-based healthcare AI company, today announced the closing of a $65M Series B funding led by Point72 Private Investments. This significant investment values Heidi at $465M and brings the company’s total funding to nearly $100M.
– The new capital will be used to accelerate Heidi’s mission of building a differentiated AI Care Partner that expands clinicians’ capacity by automating tasks such as clinical documentation, evidence search, and follow-up communications.
Returning Time to the Frontline: The Impact of AI
The investment comes as doctors and health systems globally face unprecedented strain and stress, with clinicians spending nearly as much time on administration as on patient care. Heidi’s platform is directly addressing this crisis:
- Time Savings: In just 18 months, Heidi has returned more than 18 million hours to frontline clinicians by streamlining administrative tasks.
- Scale of Impact: Tens of thousands of clinicians from over 200 medical specialties use Heidi, which supports over two million consults weekly in 110 languages across 116 countries.
- Customer Satisfaction: In a recent KLAS survey, 100% of Heidi’s surveyed customers said they would buy the tools again.
Customers are seeing major ROI, as exemplified by:
- Indiana Health Group, which saved 2,000 hours of documentation time and recovered clinical time valued at approximately $200,000 in the first five months.
- Advanced Urology, which achieved a 10.3x ROI on setup costs and recovered over $121,000 in productive clinical time in just 16 weeks.
Dr. Thomas Kelly, CEO and co-founder of Heidi and a former vascular surgical resident, stated that building a sustainable healthcare system requires expanding clinical capacity without compromising clinician wellbeing or patient safety.
Global Expansion Plans
Heidi is aggressively expanding its headcount, office locations, and local support in the USA, UK, and Canadian markets, building on clinician-led adoption across Europe and Asia.
The company has secured major partnerships globally:
- UK: Selected by Modality Partnership in the largest deployment of ambient AI in the UK, and is in pilot programs with NHS Trusts serving a local population of nearly 4 million people.
- USA: Working with large hospital networks, including Beth Israel Lahey Health in Massachusetts and MaineGeneral in Maine.
- Australia & New Zealand: Partnering with Monash Health and Queensland Health’s Children’s Hospital and is formally endorsed by the New Zealand Health Ministry as one of two healthcare AI providers safe to trial in the public health system.
- Canada: The official choice of the Yukon Government.
Executive Appointments
The company also announced the appointment of Paul Williamson (previously Head of Revenue at Plaid) as Chief Revenue Officer and Dr. Simon Kos (previously Chief Medical Officer of Microsoft) as Chief Medical Officer. Dr. Kos emphasized that Heidi’s bold vision extends beyond ambient voice technology, aiming for a future where every clinician can leverage AI to expand their clinical capacity while protecting the human touch in healthcare.
